{"changeSha256":"82d7775c60a0af7dcca9400fb12b628a08c25f5d1868c5f52a05a2f1516ab3ac","changedAt":"2026-07-27","changedFields":[{"after":"A GLP-1 receptor agonist. This profile cites a Wegovy label and an FDA notice.","before":"A GLP-1 receptor agonist represented by an exact current Wegovy label record and an FDA notice.","field":"Profile summary"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/semaglutide/versions/2/","version":2},"id":"profile:semaglutide:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-updated","notice":"We rewrote the profile summary to describe the cited public record more directly. The cited sources and status did not change.","peptideSlugs":["semaglutide"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/semaglutide/versions/1/","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"dailymed-semaglutide-ee06186f-2aa3-4990-a760-757579d8f77b-v19","name":"DailyMed · U.S. National Library of Medicine","sourceClass":"A","title":"WEGOVY (semaglutide) injection and tablet · SPL version 19 · published 2026-06-30","url":"https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=ee06186f-2aa3-4990-a760-757579d8f77b&version=19","verifiedAt":"2026-07-22"},{"id":"fda-semaglutide-2026","name":"U.S. Food and Drug Administration","sourceClass":"A","title":"FDA approves higher-dose semaglutide","url":"https://www.fda.gov/news-events/press-announcements/fda-approves-fourth-product-under-national-priority-voucher-program-higher-dose-semaglutide","verifiedAt":"2026-07-22"}],"subject":{"slug":"semaglutide","type":"profile"}}